Dai Wenxin

Chief Physician

I. Alzheimer’s disease diagnosis and treatment and other geriatric diseases diagnosis and treatment. II. Respiratory system, cardiovascular system, nervous system, geriatric diseases and other multidisciplinary diseases diagnosis and treatment. III. Tumor genetic diagnosis and chemotherapy, targeted therapy, immunotherapy, microenvironment therapy, integrated precision therapy. IV. Hypertension, hyperlipidemia, hyperuricemia, and hyperglycemia genetic diagnosis and precision therapy. V. Stem cells and gene programming and other new biomedical technologies, insulin pumps, diabetes reversal and other new technologies. VI. High-intensity focused ultrasound (HIFU) for benign and malignant tumors. VII. Gut microbiota modulation for chronic diseases and mental health disorders. VIII.Bronchoscopy, mediastinoscopy, thoracoscopy, and other internal endoscopic diagnostic and therapeutic techniques. IX. Sleep medicine. X. Chronic disease management.

Introduction of the expert

Executive Director of the Geriatric Multidisciplinary Diagnosis and Treatment Center, Chief Physician, Professor, Ph.D. Candidate, Postdoctoral Fellow, and Master’s Supervisor. Graduated from Xi’an Jiaotong University, then pursued advanced studies at Central South University, earning a Master’s degree and a Doctoral degree. In 2018, he attended Chonbuk National University in South Korea, earning a Doctor of Medical Engineering degree in BiomedicalConvergence, and conducted postdoctoral research in the field of colon cancer. Besides, he has been invited multiple times to the United States, Dubai, Italy, and other countries for academic exchanges. 

Previously employed at Tongji Medical University and Hainan Provincial People’s Hospital. Since 2011, he has been responsible for healthcare services for central government leaders visiting Hainan, provincial-level leaders, and the Boao Forum for Asia. During the 2015 Boao Forum for Asia, he successfully identified and contained a norovirus infection and transmission. During the work period, his honors include National Healthcare System Expert, Hainan Outstanding Youth Expert, model of Professional Ethics, peer reviewer for several international medical journals, director of Pre-hospital Emergency Medical Treatment Team, member of the Pharmaceutical Affairs Management Committee, and expert on Special-Class Antibiotics. 

He has led 3 provincial and ministerial-level research projects, published over 70 papers, including 7 SCI-indexed papers; Simultaneously, he pioneered the research and development of therapeutic vaccines for solid tumors and antioxidants for solid tumors. 

Medical specialty

I. Alzheimer’s disease diagnosis and treatment and other geriatric diseases diagnosis and treatment.

II. Respiratory system, cardiovascular system, nervous system, geriatric diseases and other multidisciplinary diseases diagnosis and treatment.

III. Tumor genetic diagnosis and chemotherapy, targeted therapy, immunotherapy, microenvironment therapy, integrated precision therapy.

IV. Hypertension, hyperlipidemia, hyperuricemia, and hyperglycemia genetic diagnosis and precision therapy.

V. Stem cells and gene programming and other new biomedical technologies, insulin pumps, diabetes reversal and other new technologies.

VI. High-intensity focused ultrasound (HIFU) for benign and malignant tumors.

VII. Gut microbiota modulation for chronic diseases and mental health disorders.

VIII.Bronchoscopy, mediastinoscopy, thoracoscopy, and other internal endoscopic diagnostic and therapeutic techniques.

IX. Sleep medicine.

X. Chronic disease management.

Direction of scientific research

Research projects in the fields of respiratory, cardiovascular, cancer and nano-biomedical engineering.

Academic association appointment

Member of the First Youth Committee of Thoracic and Cardiovascular Professional Committee of Hainan Rehabilitation Medical Association
Expert of Expert Group on Risk Communication for Food Safety and Nutrition Health in Hainan Province

Papers and works

He has published more than 70 papers, including 7 SCI papers (with a total factor of over 25 points).